INNOSPEC INC. (IOSP) Stock

MaterialsSpecialty Chemicals Website

6 of the hedge funds AlphaScala tracks reported IOSP in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $15.06M.

Which hedge funds own IOSP?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Renaissance Technologies
Jim Simons (founder)
185K$15.06M+56%
D.E. Shaw
David Shaw
166K$13.49M-42%
Citadel
Ken Griffin
99K$8.02M-55%
Point72
Steve Cohen
43K$3.47M-74%
Marshall Wace23K$1.88M-31%
Blackstone19K$1.56MNEW

13F holdings as of Jun 30, 2026

Explore all tracked funds →

IOSP price chart

Powered by TradingView

What does INNOSPEC INC. do?

Innospec Inc. is a global specialty chemicals company that develops, manufactures, and supplies a broad range of chemical solutions to various industries. With its primary function centered around providing performance-driven products, Innospec plays a vital role in the fuel, oilfield, and personal care sectors. This company is renowned for its fuel additives, which enhance engine performance and reduce emissions, as well as for its oilfield chemicals that optimize drilling and production operations. Additionally, Innospec's personal care and fragrance offerings enrich products in the beauty and fragrance industries. In the financial markets, Innospec Inc. holds significance by addressing niche demands within the chemical space, offering innovative solutions that balance technical prowess with environmental responsibility. Its operations span across different geographic markets, creating a diversified business model that underpins its stability and growth potential. By continually investing in research and development, Innospec sustains its competitive edge and meets evolving regulatory standards, ensuring robust participation in its respective industries. Founded in 1938, Innospec is headquartered in Englewood, Colorado, and is recognized for its commitment to sustainability and advanced chemical technology.

CEO
Mr. Patrick S. Williams
Employees
2,450
Ask about IOSPAI research agent